Dramatic response of metaplastic breast cancer to chemo-immunotherapy

被引：0
|
作者：
Sylvia Adams
机构：
[1] New York University School of Medicine,
[2] Perlmutter Cancer Center,undefined
来源：
npj Breast Cancer | / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Frequent overexpression of programmed death-ligand 1 has recently been demonstrated in metaplastic breast cancer, which is a rare breast cancer subtype with limited treatment options. This report describes the clinical course of a patient with metastatic metaplastic breast cancer who had a remarkable response to anti-programmed death-1 therapy with pembrolizumab in combination with nab-paclitaxel. Tissue correlates are presented including tumor-infiltrating lymphocytes and high-programmed death-ligand 1 expression in the tumor.
引用
收藏
相关论文
共 50 条
  • [31] Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
    Qiu, Xinyun
    Qu, Yan
    Guo, Beibei
    Zheng, Huan
    Meng, Fenghua
    Zhong, Zhiyuan
    JOURNAL OF CONTROLLED RELEASE, 2022, 341 : 498 - 510
  • [32] Codelivery of Shikonin and siTGF-β for enhanced triple negative breast cancer chemo-immunotherapy
    Li, Ji
    Zhao, Ming
    Liang, Wendi
    Wu, Siwen
    Wang, Zheran
    Wang, Dongkai
    JOURNAL OF CONTROLLED RELEASE, 2022, 342 : 308 - 320
  • [33] Systematic identification of the chemo-immunotherapy synergism to overcome immunotherapy resistance in cancer
    Wang, Yue
    Wang, Yifei
    Wang, Xiaofei
    Wang, Zehua
    Zhang, Min
    Yang, Da
    CANCER RESEARCH, 2022, 82 (12)
  • [34] CHEMO-IMMUNOTHERAPY OF BRONCHOGENIC CARCINOMA
    SARNA, GP
    LOWITZ, BB
    HASKELL, CM
    CLINE, MJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 89 - 89
  • [35] Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer
    Perry, Lauren M.
    Sevilimedu, Varadan
    Polidorio, Natalia
    Abuhadra, Nour
    Morrow, Monica
    Plitas, George
    Downs-Canner, Stephanie
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S102 - S102
  • [36] Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer
    Perry, Lauren M.
    Sevilimedu, Varadan
    Polidorio, Natalia
    Abuhadra, Nour
    Morrow, Monica
    Plitas, George
    Downs-Canner, Stephanie
    ANNALS OF SURGICAL ONCOLOGY, 2025,
  • [37] Topical chemo-immunotherapy of melanoma
    Mizes, A.
    Carey, C. D.
    Friedman, B.
    Zhang, J.
    Korkmaz, E.
    Balmert, S.
    Erdos, G.
    Falo, L. D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S9 - S9
  • [38] CHEMO-IMMUNOTHERAPY OF CANINE LYMPHOSARCOMA
    CROW, SE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 212 - 212
  • [39] Targeted chemo-immunotherapy of leukemia
    Khazaie, Khashayarsha
    LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1353 - 1354
  • [40] LYMPHOCYTE FUNCTION AND RESPONSE TO CHEMO-IMMUNOTHERAPY IN PATIENTS WITH METASTATIC MELANOMA
    THATCHER, N
    PALMER, MK
    GASIUNAS, N
    CROWTHER, D
    BRITISH JOURNAL OF CANCER, 1977, 36 (06) : 751 - 762
12345